HPV testing for clarifying borderline cervical smear results.
作者信息
Manos M M
出版信息
BMJ. 2001 Apr 14;322(7291):878-9. doi: 10.1136/bmj.322.7291.878.
Abstract
摘要
相似文献
1
HPV testing for clarifying borderline cervical smear results.
BMJ. 2001 Apr 14;322(7291):878-9. doi: 10.1136/bmj.322.7291.878.
2
Adding a test for human papillomavirus DNA to cervical-cancer screening.
N Engl J Med. 2003 Feb 6;348(6):489-90. doi: 10.1056/NEJMp020178.
3
Re: Emerging technologies and cervical cancer.
J Natl Cancer Inst. 2000 Jun 21;92(12):1014. doi: 10.1093/jnci/92.12.1014.
4
Human papillomavirus testing for primary cervical cancer screening.
JAMA. 2000 Jan 5;283(1):108-9. doi: 10.1001/jama.283.1.108.
5
[Screening for uterine cervical cancer in Belgium in 2003].
Rev Med Liege. 2003 May;58(5):316-8.
6
A causal role for human papillomavirus in head and neck cancer.
Lancet. 2004 May 8;363(9420):1488-9. doi: 10.1016/S0140-6736(04)16194-1.
7
Why am I scared of HPV?
CA Cancer J Clin. 2004 Sep-Oct;54(5):245-7. doi: 10.3322/canjclin.54.5.245.
8
HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.
Br J Cancer. 2001 Aug 3;85(3):398-404. doi: 10.1054/bjoc.2001.1926.
9
The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
Rev Med Chir Soc Med Nat Iasi. 2012 Apr-Jun;116(2):536-9.
10
Detection and typing of human papillomavirus in cervical cancer in the Thai.
J Med Assoc Thai. 1996 Dec;79 Suppl 1:S56-64.
引用本文的文献
1
Human papillomavirus testing. Authors' comments.
BMJ. 2001 Jul 14;323(7304):109.
本文引用的文献
1
Human papillomavirus testing and the management of women with mildly abnormal cervical smears: an observational study.
BMJ. 2001 Apr 14;322(7291):893-4. doi: 10.1136/bmj.322.7291.893.
2
Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.
J Natl Cancer Inst. 2001 Feb 21;93(4):293-9. doi: 10.1093/jnci/93.4.293.
3
ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.
Acta Cytol. 2000 Sep-Oct;44(5):726-42. doi: 10.1159/000328554.
4
Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group.
J Natl Cancer Inst. 2000 Mar 1;92(5):397-402. doi: 10.1093/jnci/92.5.397.
5
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
JAMA. 1999 May 5;281(17):1605-10. doi: 10.1001/jama.281.17.1605.
6
Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses.
Obstet Gynecol. 1998 Jun;91(6):973-6. doi: 10.1016/s0029-7844(98)00080-5.
7
Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL.
J Fam Pract. 1998 Feb;46(2):136-41.
8
Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.
Am J Obstet Gynecol. 1995 Mar;172(3):946-54. doi: 10.1016/0002-9378(95)90026-8.
Zotero 插件